Bank of Montreal’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bank of Montreal’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,668	Closed	-$339K	–	5096
2019 Q4	$339K	Buy	5,668 +1,721	+44%	+$64.6K	﹤0.01%	2877
2019 Q3	$111K	Sell	3,947 -159	-4%	-$5.43K	﹤0.01%	3240
2019 Q2	$155K	Buy	4,106 +3,655	+810%	+$140K	﹤0.01%	3072
2019 Q1	$18K	Sell	451 -527	-54%	-$15.1K	﹤0.01%	3718
2018 Q4	$21K	Buy	978 +261	+36%	+$6.73K	﹤0.01%	3635
2018 Q3	$28K	Sell	717 -2	-0.3%	-$75	﹤0.01%	3597
2018 Q2	$28K	Buy	719 +268	+59%	+$9.93K	﹤0.01%	3638
2018 Q1	$14K	Hold	451	–	–	﹤0.01%	3671
2017 Q4	$14K	Hold	451	–	–	﹤0.01%	3697
2017 Q3	$13K	Hold	451	–	–	﹤0.01%	3636
2017 Q2	$9K	Buy	+451	New	+$7.2K	﹤0.01%	3758

Bank of Montreal's BOLD Position: Q1 2020 in Review

Bank of Montreal sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 5,668 shares — an estimated $339K sold.

Bank of Montreal first reported a position in BOLD in Q2 2017 and held it in 11 quarters. The position peaked at $339K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Bank of Montreal reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Bank of Montreal sold 5,668 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $339K.
Bank of Montreal first reported a position in Audentes Therapeutics, Inc in Q2 2017 and held it in 11 quarters.
Bank of Montreal's Audentes Therapeutics, Inc position peaked at $339K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.